[{"orgOrder":0,"company":"Alchem International Private Ltd","sponsor":"AIIMS","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"INDIA","productType":"Plant Extract\/Herbal","year":"2021","type":"Inapplicable","leadProduct":"Curcuminoid","moa":"||Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"Alchem International Private Ltd","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Oral Troche\/Lozenge","sponsorNew":"Alchem International Private Ltd \/ AIIMS","highestDevelopmentStatusID":"1","companyTruncated":"Alchem International Private Ltd \/ AIIMS"},{"orgOrder":0,"company":"Brigham and Women's Hospital","sponsor":"University of California, Los Angeles | POM Wonderful","pharmaFlowCategory":"DU","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"","productType":"Plant Extract\/Herbal","year":"2020","type":"Inapplicable","leadProduct":"Ellagic acid","moa":"Undisclosed","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Undisclosed","graph3":"Brigham and Women's Hospital","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Brigham and Women's Hospital \/ University of California, Los Angeles | POM Wonderful","highestDevelopmentStatusID":"1","companyTruncated":"Brigham and Women's Hospital \/ University of California, Los Angeles | POM Wonderful"},{"orgOrder":0,"company":"Integrative Skin Science and Research","sponsor":"Verdure Sciences","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Plant Extract\/Herbal","year":"2020","type":"Inapplicable","leadProduct":"Ellagic acid","moa":"Immune","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Integrative Skin Science and Research","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Integrative Skin Science and Research \/ Verdure Sciences","highestDevelopmentStatusID":"1","companyTruncated":"Integrative Skin Science and Research \/ Verdure Sciences"}]

Find Clinical Drug Pipeline Developments & Deals for Ellagic acid

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Details : After ten days of treatment with Phytorelief along with standard management, 83% of Covid-19 patients, with mild or moderate symptoms, turned negative in a trial conduct in AIIMS Patna.

                          Product Name : Phytorelief-CC

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          October 06, 2021

                          Lead Product(s) : Curcuminoid,Ellagic acid,Gingerol

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Undisclosed

                          Sponsor : AIIMS

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Alchem

                          02

                          Integrative Skin Science and Research

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Integrative Skin Science and Research

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          October 22, 2020

                          Lead Product(s) : Ellagic acid

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : Verdure Sciences

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          Brigham and Women's Hospital

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Brigham and Women's Hospital

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          May 20, 2020

                          Lead Product(s) : Ellagic acid

                          Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

                          Highest Development Status : Undisclosed

                          Sponsor : University of California, Los Angeles | POM Wonderful

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          University of Texas at Austin

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          University of Texas at Austin

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          August 23, 2017

                          Lead Product(s) : Ellagic acid

                          Therapeutic Area : Musculoskeletal

                          Highest Development Status : Undisclosed

                          Sponsor : POM Wonderful

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          University of California, Los Angeles

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          University of California, Los Angeles

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          March 20, 2014

                          Lead Product(s) : Ellagic acid

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Phase II

                          Sponsor : POM Wonderful

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          POM Wonderful

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          POM Wonderful

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          May 10, 2012

                          Lead Product(s) : Ellagic acid

                          Therapeutic Area : Endocrinology

                          Highest Development Status : Phase I

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          07

                          POM Wonderful

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          POM Wonderful

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : POMx Extract

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          October 13, 2010

                          Lead Product(s) : Ellagic acid

                          Therapeutic Area : Psychiatry/Psychology

                          Highest Development Status : Phase II

                          Sponsor : Target Health Inc.

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          08

                          POM Wonderful

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          POM Wonderful

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          October 13, 2010

                          Lead Product(s) : Ellagic acid

                          Therapeutic Area : Musculoskeletal

                          Highest Development Status : Phase I

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          09

                          Vancouver Coastal Health

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Vancouver Coastal Health

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          April 09, 2010

                          Lead Product(s) : Ellagic acid

                          Therapeutic Area : Oncology

                          Highest Development Status : Undisclosed

                          Sponsor : Lotte & John Hecht Memorial Foundation

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank